Acura Pharmaceuticals, Inc.Palatine, IL, United States (NASDAQ (CM): ACUR)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

Acura Pharmaceuticals Financial Statements

Acura Pharmaceuticals Financial Information

Company Type Public
Headquarters
Fiscal Year-End December
Annual Report Company Web Site
Edgar Online logo
This data is provided as per license from EDGAR Online

Acura Pharmaceuticals Income Statement

  2007 2006 2005
Revenue ($ mil.) 6.4 0.0 0.0
Gross Profit ($ mil.) -- -- --
Operating Income ($ mil.) (4.9) (10.8) (11.6)
Total Net Income ($ mil.) (4.3) (6.0) (12.1)
Diluted EPS (Net Income) (0.11) (0.80) (1.80)
More Acura Pharmaceuticals financial information

Acura Pharmaceuticals Stock Quote & Chart

10/10/08 15:00:24 EST • NASDAQ • 5.55 • Decreased by -0.4300 • Decreased by -7.1906 %
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
Detailed QuoteInteractive Stock Chart

Acura Pharmaceuticals Financial Ratios

  Company Industry
Median		 Market
Median1
Price/Sales Ratio 8.91 3.75 1.56
Price/Earnings Ratio 16.34 16.34 15.82
Price/Book Ratio 10.28 2.92 1.52
Price/Cash Flow Ratio 12.42 13.17 9.88
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.

Detailed Acura Pharmaceuticals Financial Ratios

Acura Pharmaceuticals Competitive Intelligence

Elite Pharmaceuticals Endo Pharmaceuticals Pain Therapeutics
Annual Sales ($ mil.) 1.4 1,085.6 66.0
Employees -- 1,208 --
Market Cap ($ mil.) 6.4 2,794.9 399.3

Competitive Landscape